Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Calcitriol, But Not Fgf23, Increases in Csf and Serum of Ms Patients Publisher Pubmed



Emami Aleagha MS1, 2 ; Siroos B3 ; Allameh A2 ; Shakiba S3 ; Ranjiburachaloo S3 ; Harirchian MH3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Department of Clinical Biochemistry, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  3. 3. Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Neuroimmunology Published:2019


Abstract

The anti-inflammatory role of the active metabolite of vitamin D, namely 1, 25-dihydroxyvitamin D3 (calcitriol), has been reported in multiple sclerosis (MS). Moreover, recent studies have shown that fibroblast growth factor 23 (FGF23) is involved in the regulation of calcitriol biosynthesis. The probable changes of FGF23 and calcitriol concentrations in the CSF and serum of patients with MS were evaluated. Calcitriol concentration in the CSF and serum of MS patients was significantly higher than that in non-MS patients, while FGF23 concentration in MS patients was comparable to controls. We concluded that calcitriol concentration increases in the CSF and serum of MS patients independent of FGF23 status. © 2018